Atlas Trials

Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis

Clinical trial NCT04819360 · TERMINATED

Trial details

NCT number
NCT04819360
Sponsor
Brigitte Schürch
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Urinary Bladder, NeurogenicMultiple Sclerosis
Start date
2021-06-01
Primary completion
2022-03-09
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.